Meetup 17 - 11.06.2019
BioTarget 2019 Final - Pitch Event
Cancer is a disease that affects far too many people, with one in two being diagnosed with cancer during their lifetime.
Scientific research has already changed the lives of many suffering from this disease, but there continues to be an urgent need for new breakthroughs in cancer drug development.
BioTarget directly addresses the urgent need for new drugs and treatments. The competition is directed at early-stage ventures aiming at developing new molecules for cancer treatment and is kindly supported by Cancer Research UK.
The competition is open to those seeking to further characterise or validate their drug target using cellular and molecular assays. We invite researchers around the world to join forces to find new drugs and bring them to market faster. Clinicians, postdoctoral researchers, established professors, virtual biotechs or even students - it is the quality of the idea that counts.
BioTarget also aims at raising awareness for entrepreneurship and innovation amongst scientists. It allows them to showcase their innovations to a greater audience and to meet leading biotech investors and industry professionals that can help them move their idea forward.
Following a first stage of the competition based on proposals submitted online, BioTarget now selects the 8 most promising projects, inviting them to a pitch event in London, UK.
During the pitch event, the finalists will present their projects, and a panel of experienced drug discovery researchers and investors will select the three winners, who will be awarded up to $100,000 in free experimentation conducted in Europe's leading cloud lab.
18:00 Arrival and registration
18:45 Finalists' pitches
19:30 Awards ceremony
20:00 Drinks reception